Evidence map›Paper›PMID 21430544›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2011

High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.

Liangjing Chen, Andrew Hadd, Sachin Sah, Jeffrey F Houghton, Stela Filipovic-Sadic, Wenting Zhang, Paul J Hagerman, Flora Tassone, Gary J Latham

Abstract readEvaluation Study
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Prosodic Differences in Women with theInternational journal of molecular sciences · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Narrative Review: Update on the Molecular Diagnosis of Fragile X Syndrome.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liangjing Chen *Diagnostic Research and Technology Development, Asuragen, Inc., Austin, Texas 78744, USA.
Andrew Hadd *Diagnostic Research and Technology Development, Asuragen, Inc., Austin, Texas 78744, USA.
Sachin SahDiagnostic Research and Technology Development, Asuragen, Inc., Austin, Texas 78744, USA.
Jeffrey F HoughtonDiagnostic Research and Technology Development, Asuragen, Inc., Austin, Texas 78744, USA.
Stela Filipovic-SadicDiagnostic Research and Technology Development, Asuragen, Inc., Austin, Texas 78744, USA.
Wenting ZhangDepartment of Biochemistry and Molecular Medicine, University of California, School of Medicine, Davis, California 95616, USA.
Paul J HagermanDepartment of Biochemistry and Molecular Medicine, University of California, School of Medicine, Davis, California 95616, USA.
Flora TassoneDepartment of Biochemistry and Molecular Medicine, University of California, School of Medicine, Davis, California 95616, USA.
Gary J LathamDiagnostic Research and Technology Development, Asuragen, Inc., Austin, Texas 78744, USA.

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
Expression of the Fragile X GeneR01HD040661 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI HAGERMAN, PAUL J · 2002 to 2016
$4.3M
Amplification Strategies for Detection of Fragile X Gene Trinucleotide RepeatsR44HD060450 · NICHD · AMBION DIAGNOSTICS, INC. · PI HADD, ANDREW G · 2010 to 2011
$1.2M
Amplification Strategies for Detection of Fragile X Trinucleotide RepeatsR43HD060450 · NICHD · AMBION DIAGNOSTICS, INC. · PI HADD, ANDREW G · 2009 to 2009
$414k
NICHD NIH HHS HD02274NICHD NIH HHS HD040661NICHD NIH HHS R01 HD040661NICHD NIH HHS R43 HD060450NICHD NIH HHS R43HD060450NICHD NIH HHS R44 HD060450NICHD NIH HHS R44HD060450
6 · The paper itself

Abstract

purposeFragile X syndrome is associated with the expansion of CGG trinucleotide repeats and subsequent methylation of the FMR1 gene. Molecular diagnosis of fragile X currently requires Southern blot analysis to assess methylation. This study describes the evaluation of a polymerase chain reaction-only workflow for the determination of methylation status across a broad range of FMR1 genotypes in male and female specimens.

methodsWe evaluated a novel method that combines allele-specific methylation polymerase chain reaction and capillary electrophoresis with eight cell line and 80 clinical samples, including 39 full mutations. Methylation status was determined using a three-step workflow: (1) differential treatment of genomic DNA using a methylation-sensitive restriction enzyme; (2) polymerase chain reaction with two sets of dye-tagged primers; and (3) amplicon sizing by capillary electrophoresis. All samples were analyzed by both methylation polymerase chain reaction and Southern blot analysis.

resultsFMR1 methylation status and CGG repeat sizing were accurately and reproducibly determined in a set of methylation controls and genomic DNA samples representing a spectrum of CGG repeat lengths and methylation states. Moreover, methylation polymerase chain reaction revealed allele-specific methylation patterns in premutation alleles that were unobtainable using Southern blot analysis.

conclusionsMethylation polymerase chain reaction enabled high throughput, high resolution, and semiquantitative methylation assessments of FMR1 alleles, as well as determinations of CGG repeat length. Results for all samples were concordant with corresponding Southern blot analyses. As a result, this study presents a polymerase chain reaction-based method for comprehensive FMR1 analysis. In addition, the identification of novel methylation mosaic patterns revealed after polymerase chain reaction and capillary electrophoresis may be relevant to several FMR1 disorders.

Indexed as

DNA MethylationBlotting, SouthernCell LineFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansMaleMutationPolymerase Chain ReactionFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID21430544
PMCPMC4043840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.